http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17421397

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article
endingPage 195
issn 1090-3798
issueIdentifier 2
pageRange 192-195
publicationName European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
startingPage 192
bibliographicCitation Battaglia T, De Grandis E, Mirabelli-Badenier M, Boeri L, Morcaldi G, Barabino P, Intra C, Naselli F, Pistoia V, Veneselli E, Conte M. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. European Journal of Paediatric Neurology. 2012 Mar;16(2):192–5. doi: 10.1016/j.ejpn.2011.05.013.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3fd8dd183106b8ddcaf2243c0f59aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9405-7339
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4f31c52db4a763786800792b774e70a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08059d455a322a38d74ad44e3c9bac06
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c982df1601c96f7d5b7f8176a6aa71eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c764c8eba7c4e8222008d6af9df75c6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87f2553a9372e10091d1cebfe8f737a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c62b498b8eea3fda3c3fdce674b6a14f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9733-9216
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_667047fdf8dba5c02e2c816b74498d4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5793b161c49c26dd4905cb2a5c74c409
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e4db5223a672ccf47916718be44457d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b97ef8174eeed97e0adaeee76efcca97
date 201203
identifier https://doi.org/10.1016/j.ejpn.2011.05.013
https://pubmed.ncbi.nlm.nih.gov/21737325
isPartOf https://portal.issn.org/resource/ISSN/1090-3798
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21440
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments
discusses http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0544940
http://id.nlm.nih.gov/mesh/M0025515
http://id.nlm.nih.gov/mesh/M0006099
http://id.nlm.nih.gov/mesh/M0000499
http://id.nlm.nih.gov/mesh/M0001333
http://id.nlm.nih.gov/mesh/M0244307
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D058846Q000627
http://id.nlm.nih.gov/mesh/D053578Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D014202Q000209
http://id.nlm.nih.gov/mesh/D007223
http://id.nlm.nih.gov/mesh/D004569
http://id.nlm.nih.gov/mesh/D020233Q000188
http://id.nlm.nih.gov/mesh/D008279
http://id.nlm.nih.gov/mesh/D000893Q000627
http://id.nlm.nih.gov/mesh/D020233Q000209
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D001259Q000209
http://id.nlm.nih.gov/mesh/D001259Q000188
http://id.nlm.nih.gov/mesh/D016756Q000627
http://id.nlm.nih.gov/mesh/D000324Q000627
http://id.nlm.nih.gov/mesh/D013064Q000209
http://id.nlm.nih.gov/mesh/D014202Q000188
http://id.nlm.nih.gov/mesh/D013064Q000188
http://id.nlm.nih.gov/mesh/D000069283
http://id.nlm.nih.gov/mesh/D004351
http://id.nlm.nih.gov/mesh/D014777Q000150
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011241Q000627
http://id.nlm.nih.gov/mesh/D002653Q000523
http://id.nlm.nih.gov/mesh/D002653Q000209
http://id.nlm.nih.gov/mesh/D003907Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10989
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8789
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d180f13a3f81bf5e3d1904187dad811f

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 67.